Poststroke Dementia
Keywords:
Poststroke dementia, Vascular Dementia, Cognitive ImpairmentAbstract
Poststroke dementia is a dementia which is detected or occurred after acute stroke. The causes of poststroke dementia are VaD, Alzheimer’s disease or mixed dementia. About 10% of stroke patients have poststroke dementia which increased morbidity and mortality after stroke. So, early recognition and management were very important.
References
Prencipe M, Ferreti C, Casini AR, et al. Stroke, disability, and dementia: results of a population survey. Stroke 1997; 28: 531–536.
Zhu L, Fratiglioni L, Guo Z, et al. Incidence of dementia in relation to stroke and the apolipoprotein Eɛ4 allele in the very old: findings from a populationbased
longitudinal study. Stroke 2000; 31: 53–60.
Andersen G, Vestergaard K, Ostergaard Riis J, et al. Intellectual impairment in the first year following stroke compared to an age-matched population
sample. Cerebrovasc Dis 1996; 6: 363–369.
Censori B, Manara O, Agostinis C, et al. Dementia after first stroke. Stroke 1996; 27: 1205–1210.
Madureira S, Guerreiro M, Ferro JM. Dementia and cognitive impairment three months after stroke. Eur J Neurol 2001; 8: 621–627.
Zhou DH, Wang JY, Li J, et al. Study on frequency and predictors of dementia after ischemic stroke: the Chongqing stroke study. J Neurol 2004; 251: 421–427.
Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis.
Lancet Neurol 2009;8:1006–1018.
Desmond DW, Bagiella E, Moroney JT, et al. The effect of patient attrition on estimates of the frequency of dementia following stroke. Arch Neurol 1998; 55: 390–394.
Kokmen E, Whisnant JP, O’Fallon WM, et al. Dementia after ischemic stroke: a populationbased study in Rochester, Minnesota (1960–1984). Neurology 1996; 46: 154–159.
Tatemichi TK, Foulkes MA, Mohr JP, et al. Dementia in stroke survivors in the stroke data bank cohort: prevalence, incidence, risk factors and computed
tomographic findings. Stroke 1990; 21: 858–866.
Inzitari D, Di Carlo A, Pracucci G, et al. Incidence and determinants of poststroke dementia as defined by an informant interview method in a hospital-based
stroke registry. Stroke 1998; 29: 2087–2093.
Hénon H, Pasquier F, Durieu I, et al. Pre-existing dementia in stroke patients: baseline frequency, associated factors and outcome. Stroke 1997; 28:2429–
2436.
Pasquier F, Leys D. Why are stroke patients prone to develop dementia? J Neurol 1997; 244: 135–142.
Ferrucci L, Guralnik JM, Salive ME, et al. Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc 1996; 44: 237–241.
Honig LS, Tang MX, Albert S, et al. Stroke and the risk of Alzheimer disease. Arch Neurol 2003; 60: 1707–1712.
Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam study. Lancet
1997; 349: 151–154.
Hénon H, Vroylandt P, Durieu I, et al. Leukoaraiosis more than dementia is a predictor of stroke recurrence. Stroke 2003; 34: 2935–2940.
Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive
impairment harmonization standards. Stroke 2006; 37: 2220-41.
Godefroy O, Fickl A, Roussel M, et al. Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation. Stroke 2011; 42: 1712-1716.
Dong Y, Venketasubramanian N, Chan BP, et al. Brief screening tests during acute admission in patients with mild stroke are predictive of vascular cognitive
impairment 3–6 months after stroke. J Neurol Neurosurg Psychiatry 2012; 83:580–585.
Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 2011; 42: 2672-2713.
Leys D, Henon H, Mackowiak-Cordoliani MA, et al. Poststroke dementia. Lancet Neurol 2005; 4: 752–759
Álvarez-Sabín J., Román G.C. Citicoline in vascular cognitive impairment and vascular dementia alter stroke. Stroke 2011; 42: S40–S43.
Lin JH, Lin RT, Tai CT, et al. Prediction of poststroke dementia. Neurology 2003; 61: 343–348.
Aevarsson O, Svanborg A, Skoog I. Seven-year survival rate after 85 years. Arch Neurol 1998; 55: 1226–1232.
Baldereschi M, Di Carlo A, Maggi S, et al. Dementia is a major predictor of death among the Italian elderly. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology 1999; 52: 709–713.
Wilkinson D, Doody R, Helme R, et al. Donepezil 308 Study Group: Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology
2003; 61: 479-486.
Kurz AF, Erkinjuntti T, Small GW, et al. Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer’s disease with cerebrovascular disease. Eur J Neurol 2003; 10: 633–640.
Zhu L, Fratiglioni L, Guo Z, et al. Incidence of dementia in relation to stroke and the apolipoprotein Eɛ4 allele in the very old: findings from a populationbased
longitudinal study. Stroke 2000; 31: 53–60.
Andersen G, Vestergaard K, Ostergaard Riis J, et al. Intellectual impairment in the first year following stroke compared to an age-matched population
sample. Cerebrovasc Dis 1996; 6: 363–369.
Censori B, Manara O, Agostinis C, et al. Dementia after first stroke. Stroke 1996; 27: 1205–1210.
Madureira S, Guerreiro M, Ferro JM. Dementia and cognitive impairment three months after stroke. Eur J Neurol 2001; 8: 621–627.
Zhou DH, Wang JY, Li J, et al. Study on frequency and predictors of dementia after ischemic stroke: the Chongqing stroke study. J Neurol 2004; 251: 421–427.
Pendlebury ST, Rothwell PM. Prevalence, incidence, and factors associated with pre-stroke and post-stroke dementia: a systematic review and meta-analysis.
Lancet Neurol 2009;8:1006–1018.
Desmond DW, Bagiella E, Moroney JT, et al. The effect of patient attrition on estimates of the frequency of dementia following stroke. Arch Neurol 1998; 55: 390–394.
Kokmen E, Whisnant JP, O’Fallon WM, et al. Dementia after ischemic stroke: a populationbased study in Rochester, Minnesota (1960–1984). Neurology 1996; 46: 154–159.
Tatemichi TK, Foulkes MA, Mohr JP, et al. Dementia in stroke survivors in the stroke data bank cohort: prevalence, incidence, risk factors and computed
tomographic findings. Stroke 1990; 21: 858–866.
Inzitari D, Di Carlo A, Pracucci G, et al. Incidence and determinants of poststroke dementia as defined by an informant interview method in a hospital-based
stroke registry. Stroke 1998; 29: 2087–2093.
Hénon H, Pasquier F, Durieu I, et al. Pre-existing dementia in stroke patients: baseline frequency, associated factors and outcome. Stroke 1997; 28:2429–
2436.
Pasquier F, Leys D. Why are stroke patients prone to develop dementia? J Neurol 1997; 244: 135–142.
Ferrucci L, Guralnik JM, Salive ME, et al. Cognitive impairment and risk of stroke in the older population. J Am Geriatr Soc 1996; 44: 237–241.
Honig LS, Tang MX, Albert S, et al. Stroke and the risk of Alzheimer disease. Arch Neurol 2003; 60: 1707–1712.
Hofman A, Ott A, Breteler MM, et al. Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer’s disease in the Rotterdam study. Lancet
1997; 349: 151–154.
Hénon H, Vroylandt P, Durieu I, et al. Leukoaraiosis more than dementia is a predictor of stroke recurrence. Stroke 2003; 34: 2935–2940.
Hachinski V, Iadecola C, Petersen RC, et al. National Institute of Neurological Disorders and Stroke-Canadian Stroke Network vascular cognitive
impairment harmonization standards. Stroke 2006; 37: 2220-41.
Godefroy O, Fickl A, Roussel M, et al. Is the Montreal Cognitive Assessment superior to the Mini-Mental State Examination to detect poststroke cognitive impairment? A study with neuropsychological evaluation. Stroke 2011; 42: 1712-1716.
Dong Y, Venketasubramanian N, Chan BP, et al. Brief screening tests during acute admission in patients with mild stroke are predictive of vascular cognitive
impairment 3–6 months after stroke. J Neurol Neurosurg Psychiatry 2012; 83:580–585.
Gorelick PB, Scuteri A, Black SE, et al. Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the American Heart Association/ American Stroke Association. Stroke 2011; 42: 2672-2713.
Leys D, Henon H, Mackowiak-Cordoliani MA, et al. Poststroke dementia. Lancet Neurol 2005; 4: 752–759
Álvarez-Sabín J., Román G.C. Citicoline in vascular cognitive impairment and vascular dementia alter stroke. Stroke 2011; 42: S40–S43.
Lin JH, Lin RT, Tai CT, et al. Prediction of poststroke dementia. Neurology 2003; 61: 343–348.
Aevarsson O, Svanborg A, Skoog I. Seven-year survival rate after 85 years. Arch Neurol 1998; 55: 1226–1232.
Baldereschi M, Di Carlo A, Maggi S, et al. Dementia is a major predictor of death among the Italian elderly. ILSA Working Group. Italian Longitudinal Study on Aging. Neurology 1999; 52: 709–713.
Wilkinson D, Doody R, Helme R, et al. Donepezil 308 Study Group: Donepezil in vascular dementia: a randomized, placebo-controlled study. Neurology
2003; 61: 479-486.
Kurz AF, Erkinjuntti T, Small GW, et al. Long-term safety and cognitive effects of galantamine in the treatment of probable vascular dementia or Alzheimer’s disease with cerebrovascular disease. Eur J Neurol 2003; 10: 633–640.
Downloads
Published
2019-02-14
How to Cite
1.
เขียนดวงจันทร์ เ. Poststroke Dementia. J Thai Stroke Soc [Internet]. 2019 Feb. 14 [cited 2024 Jul. 1];14(3):146-52. Available from: https://he01.tci-thaijo.org/index.php/jtss/article/view/172361
Issue
Section
Original article
License
ข้อความภายในบทความที่ตีพิมพ์ในวารสารสมาคมโรคหลอดเลือดสมองไทยเล่มนี้ ตลอดจนความรับผิดชอบด้านเนื้อหาและการตรวจร่างบทความเป็นของผู้นิพนธ์ ไม่เกี่ยวข้องกับกองบรรณาธิการแต่อย่างใด การนำเนื้อหา ข้อความหรือข้อคิดเห็นของบทความไปเผยแพร่ ต้องได้รับอนุญาตจากกองบรรณาธิการอย่างเป็นลายลักษณ์อักษร ผลงานที่ได้รับการตีพิมพ์ในวารสารเล่มนี้ถือเป็นลิขสิทธิ์ของวารสาร
